Hyponatremia in COVID-19 patient using angiotensin type 1 receptor (AT1R) blocker and diuretic: a case report

Hyponatremia in COVID-19 patient using angiotensin type 1 receptor (AT1R) blocker and diuretic: a case report

Bibliographic Details
Main Authors:	Muhammed Yaşar Sever, Nedim Uzun, Serkan Ceritli, Halil Mutlu, Atıf Bayramoğlu
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences Press 2020-02-01
Series:	Journal of Research in Clinical Medicine
Online Access:	https://jrcm.tbzmed.ac.ir/PDF/jrcm-8-22.pdf

Similar Items

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
by: John D Bisognano, et al.
Published: (2007-11-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01)

Synergistic inhibitory effect of angiotensin II receptor blocker and thiazide diuretic on the tissue renin-angiotensin-aldosterone system
by: Michihiro Yoshimura, et al.
Published: (2010-06-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
by: Volpe M, et al.
Published: (2012-06-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
by: Eiichiro Yamamoto, et al.
Published: (2012-01-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
by: Eiichiro Yamamoto, et al.
Published: (2013-01-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats.
by: Eiichiro Yamamoto, et al.
Published: (2013-01-01)

Prevalence and incidence of hyponatremia and their association with diuretic therapy: Results from North India
by: Abhishek Singh, et al.
Published: (2019-01-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
by: Hyun Woong Lee
Published: (2014-12-01)

Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects
by: Thomas Unger, et al.
Published: (2000-06-01)

Angiotensin receptor blockers in heart failure
by: Jan Östergren, et al.
Published: (2003-09-01)

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01)

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008
by: Irina Evgen'evna Chazova, et al.
Published: (2009-03-01)

A study on the usefulness of diuretics combined with alpha blockers in the treatment of nocturia
by: Ankush Gupta, et al.
Published: (2009-01-01)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
by: Graham J. Moore, et al.
Published: (2021-07-01)

Place of angiotensin receptor blockers in antihypertensive therapy
by: A I Martynov, et al.
Published: (2014-03-01)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
by: Tien M.H. Ng, et al.
Published: (2020-08-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers.
by: Shin-Ichiro Miura, et al.
Published: (2013-01-01)

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin
by: Pieter Spincemaille, et al.
Published: (2014-10-01)

Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan
by: Masanori Abe, et al.
Published: (2015-03-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
by: Ji-Guang Wang
Published: (2009-07-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptor Blockers and Pneumonia risk
by: Chia-Lin Liu, et al.
Published: (2010)

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
by: Ye-Ping Ma, et al.
Published: (2020-05-01)

The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers
by: Michio Fukuda, et al.
Published: (2019-03-01)

Clinical pharmacology of angiotensin II receptor blockers: valsartan
by: M. V. Leonova
Published: (2014-12-01)

Angiotensin receptor blocker-induced bilateral ciliochoroidal effusion
by: Kanika Aggarwal, et al.
Published: (2020-01-01)

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
by: Ram CV
Published: (2011-05-01)

Use of angiotensin receptor blockers for the treatment of hypertension in India
by: H.S. Malhi
Published: (2014-11-01)

The Correlation of Angiotensin II Receptor Blockers with Myocardial Infarction
by: Fu-Hsiung Hsu, et al.
Published: (2011)

An alternative synthesis of Azilsartan: an angiotensin II receptor blocker
by: Garaga Srinivas, et al.
Published: (2015-06-01)

Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
by: Georg Nickenig, et al.
Published: (2006-03-01)

Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
by: Prakash C Deedwania, et al.
Published: (2006-03-01)

Angiotensin Receptor Blockers: Cardiovascular Protection in the Metabolic Syndrome
by: Prakash C Deedwania, et al.
Published: (2006-03-01)

Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers
by: Georg Nickenig, et al.
Published: (2006-03-01)

Thiazide diuretic-caused hyponatremia in the elderly hypertensive: will a bottle of Nepro a day keep hyponatremia and the doctor away? Study protocol for a proof-of-concept feasibility trial
by: Marcel Ruzicka, et al.
Published: (2018-04-01)

Angiotensin receptor blocker selectivity at the AT- and AT-receptors: conceptual and clinical effects
by: Thomas Unger, et al.
Published: (2000-06-01)

Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin
by: Yan Zhang, et al.
Published: (2014-09-01)